IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$67.30 USD
+0.30 (0.45%)
Updated May 22, 2024 04:00 PM ET
After-Market: $67.34 +0.04 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.19 | 2.11% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.31 per share. This reflects a positive earnings surprise of 48.39%. Look out for ITCI's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 57.78%.
Earnings History
Price & Consensus
Zacks News for ITCI
Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services